Apoptosis involves the proteolysis of specific cellular proteins by a group of cysteine proteases known as caspases. Many of these cellular targets are either functionally inactivated (e.g. poly(ADP-ribose) polymerase) or activated (e.g. other caspases, gelsolin) by such processing, thereby facilitating the cell death process. Caspase 3 is involved in the processing of many of these proteins. Recently, however, it was reported that caspase 3 is dispensable for the cleavage of a large number of cellular caspase substrates during apoptosis. Among these substrates is DFF-45/ICAD, a subunit of the heterodimeric DNA fragmentation factor (DFF), otherwise known as caspase-activated DNase (CAD), that mediates genomic DNA degradation during apoptosis. Conversely, others have reported that caspase 3 is essential for the cleavage and activation of DFF-45/ICAD. To resolve this controversy we examined DFF-45/ICAD processing during apoptosis in MCF-7 breast carcinoma cells that lack functional caspase 3 and in MCF-7 cells expressing caspase 3. We found that DFF-45/ICAD is cleaved by two distinct caspases, one of which is caspase 3. Furthermore, cleavage of the carboxyl-terminal region of DFF-45/ICAD, which is necessary for activation of the enzyme, requires functional caspase 3. In the absence of caspase 3 cleavage of the amino-terminal region of DFF-45/ICAD by another caspase occurs, but the DFF-45 enzyme remains inactive.
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These results are somewhat controversial because others have clearly shown that the DFF-45 and gelsolin require caspase 3 for proper cleavage and activation (22) (23) (24) (25) . We therefore decided to re-examine these results using the same experimental system, the breast carcinoma cell line MCF-7, which lacks functional caspase 3 (20) . Our results demonstrate that gelsolin is, in fact, not cleaved or functionally activated in these cells unless functional caspase 3 is concomitantly expressed. Furthermore, we found that only one of two known caspase cleavage sites in DFF-45, an amino-terminal site, is cleaved in the absence of caspase 3. Cleavage of the carboxyl-terminal caspase cleavage site in DFF-45 occurs only when caspase 3 is expressed, and the resulting product is capable of inducing chromatin condensation and DNA fragmentation. These results point out the rather complex nature of caspase processing of apoptotic substrates and * This research was supported by National Institutes of Health Grant GM 44088 (to V. J. K.), by National Institutes of Health Cancer Center Core Grant CA 21765 (awarded to SJCRH), and by support from the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Dept. support the conclusion that caspase 3 is required for proper cleavage and activation of both gelsolin and DFF-45.
EXPERIMENTAL PROCEDURES
Cell Lines, Expression Constructs, and Transfections-Human MCF-7 breast carcinoma cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum. For TNF-induced cell death analysis, cells at a density of 90% confluency were treated with TNF␣ at 30 ng/ml and cycloheximide (CHX) at 10 g/ml for 16 h. Stuarosporine (STS)-induced apoptosis was accomplished by incubating cells with 1.0 M STS for 16 h, unless otherwise indicated. Apoptotic cells were examined by a light microscope for appearance of the plasma membrane blebbing and by TUNEL assay (26) .
The MCF-7/neo and MCF-7/CPP32 cell lines were generated by resuspending 10 7 MCF-7 cells in 0.8 ml of PBS containing 20 g of either PCDNA3.0 or PCDNA3.0/CPP32 (kindly provided by Dr. V. Dixit), which were then electroporated using a 4 mM gap cuvette at 0.325 kV, 960 microfarads. Cells were then cultured for 48 h before addition of G418 (Geneticin, Life Technologies, Inc.) at 1 mg/ml. After 4 weeks selection in the G418 medium, a subpopulation of transfected cells expressing a moderate-high level of CPP32 was generated. Bulk populations of transfected, neo-resistant MCF-7 cells, as well as clonal cell lines, were used in many of the same experiments. By Western blot analysis, the MCF-7/CPP32 cells were found to express levels of wild type CPP32 equivalent to the levels expressed in other cell lines (e.g. HeLa) that normally express this caspase.
Cell Lysis and Immunoblotting-For Western blotting, cells were lysed in a buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 5 mM EGTA, 10 mM NaF, 10 mM ␤-glycerophosphate, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, 1 mM benzamidine, and 1 mM AEBSF (Boehringer Mannheim). 50 g of cell lysate was separated by SDS-polyacrylamide gel electrophoresis and transferred onto Immobilon-P membrane (Millipore). The resulting membrane was blocked with 10% skim milk and incubated with a designated primary antibody, and the signals were detected by use of an ECL Western blotting kit (Amersham Pharmacia Biotech). The caspase 3 (Transduction Laboratories), Bcl-x L (Transduction Laboratories), DFF45/C5 (Santa Cruz), DFF45/NT (Millennium Biotechnology), and gelsolin (Transduction Laboratories) antibodies were obtained commercially.
Induction of Caspase Cleavage and Activation and DNA Fragmentation-TNF␣/CHX and STS-induced caspase activation in MCF-7 cells was monitored by cleavage of gelsolin, DFF-45, and the transfected CPP32 using Western blot analysis. DNA fragmentation was analyzed by agarose gel electrophoresis as described previously (27) . Briefly, following treatment 10 6 cells were lysed in 0.5 ml of buffer containing 50 mM Tris (pH 8.0), 10 mM EDTA, 0.5% N-lauroylsarcosine, 0.4 mg/ml proteinase K, and 0.2 mg/ml RNase A at 37°C for 15 h. DNA was then extracted with phenol and chloroform and ethanol-precipitated. 2 g of total DNA was then analyzed by electrophoresis on a 2% agarose-1X TBE gel.
Cell Death Assays-Apoptotic cells were examined by light microscopy for morphological changes and quantified by either trypan blue uptake for STS-initiated cell death or by the standard TNF cytotoxicity assay (28, 29) . Briefly, cells were washed twice with PBS and stained for viable cells with 20% methanol containing 150 mM NaCl and 0.5% crystal violet for 15 min at room temperature. After removing excess dye with PBS, the staining dye was solubilized in 33% acetic acid and measured at A 550 with a spectrophotometer. The percentage of dead cells was defined as (1 -A 550(tested) /A 550(control) ) ϫ 100.
RESULTS

The Effects of Exogenously Expressed CPP32 on MCF-7 Cell
Death-A human CPP32/caspase 3 cDNA expression construct was stably introduced into the human breast carcinoma cell line MCF-7, which lacks this enzyme because of small interstitial deletions within the corresponding gene (20) . Western blot analysis of the vector-transfected control cells versus those transfected with the CPP32 construct demonstrates that CPP32 is expressed at moderate levels in these cells (Fig. 1A) . Because pro-CPP32 is normally expressed in viable cells, we reasoned that many of the reports of enhanced cell death induced by transient expression of this protein might reflect extremely high levels of expression in these cells (21) . In fact, we observed that within 24 h of transfection cell populations stabilized and remained stable until 1-2 weeks post-G418 addition. To determine whether CPP32 expression sensitized MCF-7 cells to apoptotic signals we compared the ability of MCF-7/neo and MCF-7/CPP32 cells to undergo apoptosis in response to either 1 M STS or TNF␣/CHX. We found that ϳ92-95% of the MCF-7/CPP32 cells apoptosed when exposed to these agents for 16 h as compared with ϳ85-92% of the MCF-7/neo controls, suggesting that expression of CPP32 does not greatly enhance the ability of these cells to die (Fig. 1B) . To ensure that the pro-CPP32 expressed in these cells was being processed appropriately following treatment with either STS or TNF␣/CHX, we examined the CPP32 protein by Western blot analysis (Fig. 1C) . As expected, CPP32 was processed appropriately to generate the 17-kDa fragment that is characteristic of the active enzyme and little, if any, of the proenzyme remained.
TNF␣/CHX and STS-induced Cleavage of Gelsolin and DFF-45 in the Absence and Presence of CPP32-One
striking difference between the MCF-7/neo and MCF-7/CPP32 cells was the morphologic changes that occurred once the cells were treated with either STS or TNF␣/CHX. Neither of these agents induced the MCF-7/neo cells to detach, whereas both stimuli were capable of inducing this phenotype in the MCF-7/CPP32 cells (data not shown). Recently, it has been shown that this The production of the CPP32 p17 subunit, which requires removal of the prodomain, is indicated. Similarly, when gelsolin is cleaved and activated during apoptosis, a p41 subunit is generated, as indicated.
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characteristic morphologic change occurs in vivo during apoptosis as a result of the cleavage of gelsolin, which when activated by CPP32 cleavage severs actin filaments in a Ca 2ϩ -independent manner in vitro (25) . We therefore decided to examine whether gelsolin was cleaved in either the MCF-7/neo or MCF-7/CPP32 cells stimulated to apoptose by the addition of either STS or TNF␣/CHX. Western blot analysis with a gelsolin antibody, which recognizes both the intact protein and the enzymatically active 41-kDa caspase cleavage product, revealed that the 41-kDa protein is not produced in CPP32
Ϫ/Ϫ cells treated with STS or TNF␣/CHX (Fig. 1C) . However, when CPP32 is expressed in the same cells and they are treated with STS or TNF␣/CHX, the 41-kDa gelsolin cleavage product is generated (Fig. 1C) . These results are consistent with those reported by Kothakota et al. (25) , but they do not agree with the conclusions reached by Janicke et al. (21) .
Because we demonstrated that gelsolin was cleaved appropriately to produce the active 41-kDa fragment only in the presence of CPP32, we decided to examine another known substrate of this enzyme, DFF-45 (22) (23) (24) . It has also been reported that DFF-45 is correctly processed in MCF-7 cells lacking functional CPP32 by Janicke et al. (21) . To perform these experiments we stimulated either MCF-7/neo or MCF-7/ CPP32 cells to undergo cell death with 1 M STS. In addition, we decided to monitor the effects of STS treatment in a timedependent manner to allow comparison of the onset of CPP32 cleavage and activation with the onset of DFF-45 cleavage and activation. This would allow us to determine whether a correlation between CPP32 activation and DFF-45 activation exists. We found that CPP32 cleavage and generation of its p17 subunit occurred within 4 h of STS treatment and that the CPP32 proenzyme was depleted from these cells within 6 -8 h of STS treatment ( Fig. 2A) . When we examined DFF-45 processing using a carboxyl-terminal DFF-45 antibody we found that, as reported by Janicke et al. (21) , the level of intact DFF-45 diminished in the MCF-7/neo cells starting at about 4 h post-STS treatment (Fig. 2B) . Concomitantly, a ϳ30-kDa DFF-45 reactive product that apparently reflects a partially processed intermediate was also produced. However, the release of a carboxyl-terminal 11-kDa fragment (p11), which is absolutely required for activation of the DNA fragmentation factor activity (23, 24), was not observed. Conversely, when we examined DFF-45 in MCF-7/CPP32 cells undergoing STS-mediated apoptosis we found that the ϳ30-kDa intermediate fragment appeared by 2 h, followed by the appearance of the p11 species (Fig. 2B) . This suggests that the 30-kDa DFF-45 intermediate most likely results from the release of the amino-terminal portion of DFF-45, leaving intact the middle and carboxyl-terminal regions of the protein. To demonstrate that protein loading was equivalent and that nonspecific proteolysis was not occurring, the same lysates from both the MCF-7/neo and MCF-7/CPP32 cells were Western blotted with a Bcl-x L antibody (Fig. 2B) . These results also suggest that the amino-terminal caspase site in DFF-45 can be cleaved by a caspase other than CPP32 in vivo and that its carboxyl-terminal caspase cleavage site can only be processed by CPP32. Fig. 2 were examined by Western blotting with a DFF-45 amino-terminal specific antiserum to determine whether this region was removed in MCF-7/neo and/or MCF-7/CPP32 cells. The p18 fragment, DFF-45 (NT), generated is indicated, as well as the DFF-45 and DFF-45-partial (in this case referring to the alternatively spliced, partial length DFF-45 protein) products. Only the DFF-45 amino-terminal specific antiserum detects the second, smaller DFF-45 alternatively spliced product (23) .
Caspase Cleavage of the Carboxyl-terminal Region of DFF-45 Is Required for Its
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the CPP32-processed DFF-45, but not the DFF-45 intermediate generated through cleavage by an unknown caspase, was functional, we examined nuclei and DNA from both STS-treated MCF-7/neo and MCF-7/CPP32 cells (Fig. 2C) . As expected, nuclei containing condensed chromatin (data not shown), as well as fragmented, laddered DNA was found only in the MCF-7/CPP32 cells treated with STS. In addition, DNA fragmentation started to appear within ϳ4 h after STS treatment, consistent with the appearance of the DFF-45 11-kDa fragment. This confirms that CPP32 activity and the release of the carboxyl-terminal p11 species are required for apoptotic nuclease activity.
Release of the Amino-terminal Region of DFF-45 Occurs in the Absence of CPP32 and Its Appearance Coincides with CPP32 Cleavage of the DFF-45 Carboxyl-terminal
Region-To conclusively demonstrate that the ϳ30-kDa DFF-45 intermediate observed in MCF-7/neo cells undergoing STS-mediated apoptosis was the result of the removal of the amino-terminal region of DFF-45, we examined these same cell lysates by Western blotting with a DFF-45 amino-terminal-specific antiserum (Fig. 3) . As expected, a ϳ17-kDa fragment (DFF45(NT)) was observed starting at 4 h post-STS treatment. Additionally, the DFF-45 amino-terminal antiserum detects two distinct polypeptides, ϳ38 and 45 kDa in size (Fig. 3) , whereas the carboxyl-terminal antiserum detects only the larger of these two protein species (Fig. 2B) . This is consistent with the presence of two alternatively spliced forms of human DFF-45, much like what has been reported in the mouse (19) . In the mouse, alternative splicing removes the carboxyl-terminal portion of the larger protein, creating a shorter polypeptide that is no longer recognized by the carboxyl-terminal antiserum; however, both forms are recognized by the amino-terminal antiserum because this region is present in both proteins.
Both the 38-and 45-kDa forms of DFF-45 appear to be processed in a similar manner in both MCF-7/neo and MCF-7/ CPP32 cells (Fig. 3) . Furthermore, in the STS-treated MCF-7/ CPP32 cells the DFF-45 (NT) species appeared at the same time as the p11 species. However, although the DFF-45 (NT) species was detected up to 8 h post-STS treatment in the MCF-7/neo cells, it quickly disappeared from the STS-treated MCF-7/CPP32 cell lysates (Fig. 3) . This might suggest that the 17-kDa DFF-45 amino-terminal fragment is rapidly turned over in the presence of CPP32 but not in its absence. The significance of this observation is not known at this time.
DISCUSSION
Here we have shown that 1) DFF-45 is cleaved by two distinct caspases during STS-induced apoptosis in vivo, 2) CPP32/ caspase 3 processes the carboxyl-terminal caspase cleavage site of DFF-45, and 3) cleavage of DFF-45 and gelsolin by CPP32/ caspase 3 is absolutely required for their activation in vivo. We have also shown that careful examination of the cleavage products of caspase substrates is required to reach definitive conclusions regarding the requirements of specific caspases for processing of substrates. In several instances Janicke et al. (21) used the diminished level of an intact caspase substrate as an indicator of its processing, but clearly this is not sufficient. Diminished levels of a particular substrate could be because of a number of physical changes that coincide with cell death, including its partitioning into an insoluble cellular fraction. Such partitioning, most likely because of substrate association with the nuclear matrix or its components, would seem reasonable for DFF-45. Recently, MEKK1 was shown to partition into a soluble cellular fraction from the insoluble cellular fraction once it underwent caspase processing, suggesting that these types of changes may be relevant to the function of certain caspase-cleaved substrates (30) . Thus, reagents that detect the caspase-processed, active (or inactive) forms of these substrates must be employed in these types of experiments. In addition, careful examination of morphologic changes that are known to accompany changes in substrate processing (e.g. activation of gelsolin) should also be incorporated into any analyses. As demonstrated in this study, MCF-7 cells lacking CPP32/ caspase 3 not only retain intact nuclei, but they also fail to detach. The latter is a hallmark of the severing of actin filaments by activated gelsolin (25) , and it should have alerted Janicke et al. (21) to possible discrepancies in their study.
Finally, analysis of the cleavage of caspase substrates in cell lines deficient in a particular functional caspase (e.g. CPP32/ caspase 3) may also help to reveal that many are processed by more than one caspase in vivo. In many instances this might go unnoticed unless such caspase Ϫ/Ϫ cell lines are utilized. Several groups have recently concluded that DFF-45 is cleaved only by the CPP32/caspase 3 protease (23, 24) . Clearly, we have shown here that whereas the carboxyl-terminal site requires CPP32/caspase 3 for its cleavage, processing of the aminoterminal site requires another, currently unidentified caspase.
